News



Notice published pursuant to an order of the Federal Court of Australia

Vaping products, medicinal cannabis and the wellness industry included in 2023-24 compliance and enforcement priorities

Sponsors and manufacturers reminded about upcoming financial deadlines

Amendments to restrictions for prescribing of MS-2 Step (Mifepristone and Misoprostol)

Nature’s Puff Pty Ltd and director fined $105,600 for alleged unlawful advertising of nicotine vaping products

ICMRA statement on the safety of COVID-19 vaccines

Nitrosamine risk assessment in Category 1 prescription medicine registration applications

Deadline for certain medical device reforms to be extended

Update on MDMA and psilocybin access and safeguards from 1 July 2023

New guidance published on manufacturer evidence for IVD medical devices

Pracmed Healthcare Pty Ltd fined $39,960 for alleged unlawful advertising

Infringement notices totalling $588,840 issued to three Sydney-based TSG stores and Jaradat and Sabbagh Group Pty Ltd

Affinity Corp Australia Pty Ltd fined $66,600 for alleged unlawful advertising of medicinal cannabis products

TGA supports MHRA’s new international recognition framework for medicines

2023 Seasonal Influenza Vaccines

Lifeblood sexual activity and PrEP deferrals

Queensland individual fined nearly $16,000 after allegedly importing unregistered nicotine vaping products

Phase out of ISO 13485 certificates for IVD medical devices

Updates to the Prescribing Medicines in Pregnancy database, May 2023
